PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 14256818

AN IMPROVED MICROBATH.

J H GADDUM
View original source ↗Export metadata ↓

Abstract

A method is described for the study of the actions of drugs and tissue extracts on small pieces of smooth muscle suspended in a bath with a capacity of 0.027 ml. The small size of the bath is an advantage when the total amount of active substance is small. The contractions are amplified 50- to 500-times and recorded isotonically, or approximately isometrically, with a pen writer. This apparatus has the advantage over earlier models that it is more compact and convenient and that the temperature of the muscle can be controlled. It has been used for the estimation of small quantities of acetylcholine and other substances in tissue extracts.

Explore related subjects

AcetylcholineAnimalsBiological AssayElectronicsEquipment and SuppliesFemaleFishesHumansIntestine, SmallIntestinesMuscle, SmoothMusclesPharmacologyRatsResearchSerotoninTissue ExtractsUterusACETYLCHOLINEBIOLOGICAL ASSAYELECTRONICSEQUIPMENT AND SUPPLIESEXPERIMENTAL LAB STUDYFISHESINTESTINE, SMALLMUSCLE, SMOOTHPHARMACOLOGYRATSSEROTONINUTERUSJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J H GADDUM. 1964. AN IMPROVED MICROBATH.. https://doi.org/10.1111/j.1476-5381.1964.tb01614.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Application of immobilized enzyme reactor in on-line high performance liquid chromatography: a review.

This review summarizes all the research efforts in the last decade (1994-2003) that have been spent to the various application of immobilized enzyme reactor (IMER) in on-line high performance liquid chromatography (HPLC). All immobilization procedures including supports, kind of assembly into chromatographic system and methods are described. The effect of immobilization on enzymatic properties and stability of biocatalysts is considered. A brief survey of the main applications of IMER both as pre-column, post-column or column in the chemical, pharmaceutical, clinical and commodities fields is also reported.

Acetylcholine↗
PubMed2005

Theoretical insights into the mechanism of acetylcholinesterase-catalyzed acylation of acetylcholine.

Acylation of acetylcholine (ACh) catalyzed by acetylcholinesterase (AChE) has been studied using high-level theoretical calculations on a model system that mimics the reaction center of the enzyme, and compared with uncatalyzed acylation reaction. The geometries of all the intermediates and transition states, activation energies, and solvent effects have been calculated. The calculations predict simultaneous formation of two short-strong hydrogen bonds (SSHB) in the rate-determining transition state structures [the first SSHB involves the hydrogen atom of Ser-200 (H(s)) and another involves the hydrogen atom of His-440 (H(h))]. In the intermediate states, the H-bond corresponding to H(h) involves SSHB, whereas the one corresponding to H(s) does not.

Acetylcholine↗
PubMed2005

3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation.

The novel cyclic dinucleotide, 3',5'-cyclic diguanylic acid, cGpGp (c-di-GMP), is a naturally occurring small molecule that regulates important signaling mechanisms in prokaryotes. Recently, we showed that c-di-GMP has "drug-like" properties and that c-di-GMP treatment might be a useful antimicrobial approach to attenuate the virulence and pathogenesis of Staphylococcus aureus and prevent or treat infection. In the present communication, we report that c-di-GMP (50 microM) has striking properties regarding inhibition of cancer cell proliferation in vitro. c-di-GMP inhibits both basal and growth factor (acetylcholine and epidermal growth factor)-induced cell proliferation of human colon cancer (H508) cells. Toxicity studies revealed that exposure of normal rat kidney cells and human neuroblastoma cells to c-di-GMP at biologically relevant doses showed no lethal cytotoxicity. Cyclic dinucleotides, such as c-di-GMP, represent an attractive and novel "drug-platform technology" that can be used not only to develop new antimicrobial agents, but also to develop novel therapeutic agents to prevent or treat cancer.

Acetylcholine↗